A phase 1 clinical trial of a new cellular immunotherapy being developed in Australia for the treatment of multiple sclerosis (MS) has found that it improved symptoms and quality of life for the majority of patients. …
Latest Video
New Stories
-
What next for payment reform?
February 20, 2019 - - Latest News -
New report calls for greater focus on secondary CV events
February 20, 2019 - - Latest News -
Fee 'crunch' for smaller companies and patient populations
February 20, 2019 - - Latest News -
Partnership to manage Biomedical Translation Bridge Program
February 20, 2019 - - Latest News -
Gilead's Rob Hetherington: 'Workplaces have come such a long way'
February 19, 2019 - - Latest News -
Department of Health reveals facts on key listing stage
February 19, 2019 - - Latest News -
Response reveals impact of higher price cut threshold
February 19, 2019 - - Latest News